Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

French biotech ImCheck Therapeutics is preparing to showcase encouraging interim results for its investigational monoclonal ...

MHH haematologists successfully treat seriously ill patients with acquired haemophilia A with CAR-T cells.

About 40 percent of cancer cases are considered preventable. Try these lifestyle changes to stay healthy.

NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Autolus Therapeutics' autologous CD19-directed CAR T-cell therapy Aucatzyl ...

John Mauceri, an award-winning music conductor, author, and recording artist, is celebrating his return to the stage in ...

This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...

A stock pop from a nuclear reactor company that doesn't have a working nuclear reactor. Mesoblast CEO Silviu Itescu joins Motley Fool host Ricky Mulvey for a conversation about how to price medical ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Nic Enright thought he would be caught up in the emotions of finally making it to the majors this past weekend. Compared to everything he has dealt with the past three years since ...